DEXTROMETHORPHAN O-DEMETHYLATION POLYMORPHISM IN FRENCH CAUCASIAN POPULATION - A FAMILIAL STUDY

被引：0
|
作者：
VINCENTVIRY, M [1 ]
GALTEAU, MM [1 ]
FOURNIER, B [1 ]
SIEST, G [1 ]
机构：
[1] CTR MED PREVENT,CNRS,URA 597,F-54501 VANDOEUVRE NANCY,FRANCE
来源：
CLINICAL CHEMISTRY | 1990年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1042 / 1042
页数：1
相关论文
共 50 条
  • [31] Variables in human liver microsome preparation:: Impact on the kinetics of L-α-acetylmethadol (LAAM) N-demethylation and dextromethorphan O-demethylation
    Nelson, AC
    Huang, W
    Moody, DE
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (03) : 319 - 325
  • [32] Evidence for the catalysis of dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver
    Jurima-Romet, M
    Casley, WL
    Leblanc, CA
    Nowakowska, M
    TOXICOLOGY IN VITRO, 2000, 14 (03) : 253 - 263
  • [33] Haloperidol metabolites inhibit CYP2D6 catalyzed dextromethorphan O-demethylation in vitro.
    Shin, JG
    Kane, K
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 143 - 143
  • [34] Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population (vol 65, pg 570, 1999)
    Tateishi, T
    Chida, M
    Ariyoshi, N
    Mizorogi, Y
    Kamataki, T
    Kobayashi, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (06) : 581 - 581
  • [35] Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine
    Abdel-Rahman, SM
    Marcucci, K
    Boge, T
    Gotschall, RR
    Kearns, GL
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (07) : 770 - 775
  • [36] DEXTROMETHORPHAN O-DEMETHYLATION IN LIVER-MICROSOMES AS A PROTOTYPE REACTION TO MONITOR CYTOCHROME-P-450 DB1 ACTIVITY
    DAYER, P
    LEEMANN, T
    STRIBERNI, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) : 34 - 40
  • [37] CYP2D6 genotyping analysis and functional characterization of novel allelic variants in a Ni-Vanuatu and Kenyan population by assessing dextromethorphan O-demethylation activity
    Rico, Evelyn Marie Gutierrez
    Kikuchi, Aoi
    Saito, Takahiro
    Kumondai, Masaki
    Hishinuma, Eiji
    Kaneko, Akira
    Chan, Chim Wai
    Gitaka, Jesse
    Nakayoshi, Tomoki
    Oda, Akifumi
    Saito, Sakae
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : 89 - 101
  • [38] Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes
    Kubota, T
    Yamaura, Y
    Ohkawa, N
    Hara, H
    Chiba, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (01) : 31 - 34
  • [39] O-Demethylation reaction at a diruthenium core:: synthesis and structural study of two novel diruthenium compounds
    Ren, T
    DeSilva, V
    Zou, G
    Lin, C
    Daniels, LM
    Campana, CF
    Alvarez, JC
    INORGANIC CHEMISTRY COMMUNICATIONS, 1999, 2 (07) : 301 - 304
  • [40] Characterization of the genetic polymorphism of dihydrocodeine O-demethylation in man via analysis of urinary dihydrocodeine and dihydromorphine by micellar electrokinetic capillary chromatography
    Hufschmid, E
    Theurillat, R
    WilderSmith, CH
    Thormann, W
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 678 (01): : 43 - 51
12345